Biocryst Pharmaceuticals (BCRX) Net Cash Flow: 2010-2015
Historic Net Cash Flow for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to -$17.7 million.
- Biocryst Pharmaceuticals' Net Cash Flow rose 73.39% to -$17.7 million in Q4 2015 from the same period last year, while for Dec 2015 it was -$25.6 million, marking a year-over-year decrease of 176.82%. This contributed to the annual value of -$5.2 million for FY2024, which is 97.33% up from last year.
- According to the latest figures from Q4 2015, Biocryst Pharmaceuticals' Net Cash Flow is -$17.7 million, which was up 41.21% from -$30.2 million recorded in Q3 2015.
- Biocryst Pharmaceuticals' Net Cash Flow's 5-year high stood at $107.9 million during Q2 2014, with a 5-year trough of -$66.6 million in Q4 2014.
- For the 3-year period, Biocryst Pharmaceuticals' Net Cash Flow averaged around $667,333, with its median value being -$5.5 million (2013).
- Its Net Cash Flow has fluctuated over the past 5 years, first soared by 2,075.23% in 2014, then tumbled by 8,229.83% in 2015.
- Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Net Cash Flow stood at -$6.0 million in 2011, then spiked by 48.84% to -$3.1 million in 2012, then slumped by 59.26% to -$4.9 million in 2013, then slumped by 1,263.43% to -$66.6 million in 2014, then soared by 73.39% to -$17.7 million in 2015.
- Its Net Cash Flow was -$17.7 million in Q4 2015, compared to -$30.2 million in Q3 2015 and $28.4 million in Q2 2015.